Andrew George Robinson
ORCID:0000-0003-1152-4275
发表论文 172 篇 · 总被引 20681 次 · h-index 36
代表论文
- Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer (2021 · Annals of Oncology · 被引 756)
- Pembrolizumab Plus Chemotherapy in Squamous Non–Small-Cell Lung Cancer: 5-Year Update of the Phase III KEYNOTE-407 Study (2023 · Journal of Clinical Oncology · 被引 563)
- Metformin in Combination With Chemoradiotherapy in Locally Advanced Non–Small Cell Lung Cancer (2021 · JAMA Oncology · 被引 113)
- Outcomes With Pembrolizumab Monotherapy in Patients With Programmed Death-Ligand 1–Positive NSCLC With Brain Metastases: Pooled Analysis of KEYNOTE-001, 010, 024, and 042 (2021 · JTO Clinical and Research Reports · 被引 89)
- Remote, proactive, telephone based management of toxicity in outpatients during adjuvant or neoadjuvant chemotherapy for early stage breast cancer: pragmatic, cluster randomised trial (2021 · BMJ · 被引 50)
- Patients’ considerations of time toxicity when assessing cancer treatments with marginal benefit (2024 · The Oncologist · 被引 40)